Derya Sevimli Saydan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Derya Sevimli Saydan has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ali Ağaçfidan
Department of Medical Microbiology, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, Turkey
4 shared publications - Arat Hulikyan
Department of Medical Microbiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul 34452, Turkey
4 shared publications - Hayriye Kirkoyun Uysal
Department of Medical Microbiology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkiye
4 shared publications - Mehmet Demirci
Department of Medical Microbiology, Faculty of Medicine, Kırklareli University, 39100 Kirklareli, Türkiye
4 shared publications - Mustafa Önel
Department of Medical Microbiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul 34093, Turkey
3 shared publications - Atahan Çağatay
Department of Infectious Diseases and Clinical Microbiology, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, Turkey
2 shared publications
Latest Publications
- Open Access
- 9 September 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (18) , 2895
Seroepidemiological Prevalence of Hepatitis B and C Virus Coinfection: A Large-Scale Retrospective Cohort Study in Istanbul
Background/Objectives: Hepatitis B (HBV) and hepatitis C (HCV) coinfection leads to the progression of liver disease and results in clinically serious outcomes. Continuous monitoring of epidemiological data is crucial for managing the regional disease burden. This study investigates the current seroprevalence of HBV and HCV, the prevalence of coinfection, and the rates of active replication in Istanbul. Methods: This retrospective analysis included 7131 patients evaluated at the Infectious Diseases and Gastroenterohepatology clinics between 2021 and 2025. Initial serological screening for viral markers was performed using routine chemiluminescent immunoassays. Active viral replication was subsequently confirmed and quantified via real-time polymerase chain reaction (PCR). Results: Active HBV replication was significantly more frequent among patients in the Gastroenterohepatology clinic (20.47%) compared to those in Infectious Diseases (5.36%). Active HCV infections were rare in both departments (0.25% and 0.04%, respectively). Simultaneous HBV and HCV coinfection was detected in only 17 patients (0.24%). Demographic evaluation demonstrated that HBV marker positivity was more prevalent in male patients and individuals over 40 years of age. Conclusions: HBV seroprevalence remains substantially higher than HCV in this cohort. The high rate of active HBV replication in gastroenterohepatology settings indicates a concentrated burden of active disease in these specialized clinics. These distribution patterns emphasize the necessity of routine, targeted HBV screening for older male demographics to facilitate early clinical intervention.
- 9 September 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (18) , 2895
Open AccessSeroepidemiological Prevalence of Hepatitis B and C Virus Coinfection: A Large-Scale Retrospective Cohort Study in Istanbul
Background/Objectives: Hepatitis B (HBV) and hepatitis C (HCV) coinfection leads to the progression of liver disease and results in clinically serious outcomes. Continuous monitoring of epidemiological data is crucial for managing the regional disease burden. This study investigates the current seroprevalence of HBV and HCV, the prevalence of coinfection, and the rates of active replication in Istanbul. Methods: This retrospective analysis included 7131 patients evaluated at the Infectious Diseases and Gastroenterohepatology clinics between 2021 and 2025. Initial serological screening for viral markers was performed using routine chemiluminescent immunoassays. Active viral replication was subsequently confirmed and quantified via real-time polymerase chain reaction (PCR). Results: Active HBV replication was significantly more frequent among patients in the Gastroenterohepatology clinic (20.47%) compared to those in Infectious Diseases (5.36%). Active HCV infections were rare in both departments (0.25% and 0.04%, respectively). Simultaneous HBV and HCV coinfection was detected in only 17 patients (0.24%). Demographic evaluation demonstrated that HBV marker positivity was more prevalent in male patients and individuals over 40 years of age. Conclusions: HBV seroprevalence remains substantially higher than HCV in this cohort. The high rate of active HBV replication in gastroenterohepatology settings indicates a concentrated burden of active disease in these specialized clinics. These distribution patterns emphasize the necessity of routine, targeted HBV screening for older male demographics to facilitate early clinical intervention.
- Open Access
Seroepidemiology and Reactivation Rates of Cytomegalovirus in HIV-Positive Patients in Istanbul: A Retrospective Analysis
Cytomegalovirus (CMV) remains a major opportunistic pathogen in individuals with HIV. The aim of this study was to investigate the seroprevalence and reactivation rates of CMV among HIV-positive individuals. A total of 300 people with HIV presenting to the Istanbul Faculty of Medicine were enrolled. Serological assessments were performed using enzyme-linked immunosorbent assay (ELISA), while molecular analyses were conducted through PCR-based methods. Sociodemographic and clinical characteristics of the patients were also evaluated. Of the participants, 90% were male, with an age range of 18–76 years. Serological testing demonstrated CMV IgG positivity in 292 patients (97.3%) and CMV IgM positivity in 11 patients (4.07%). CMV DNA was detected in 91 patients (30.3%) by molecular assays, with viral loads ranging from p < 0.05) and was associated with lower CD4+ T lymphocyte counts. CMV disease was identified in 50 patients (16.7%), with organ involvement (64%) representing the most common clinical manifestation. CMV seropositivity is remarkably high in HIV-positive individuals, and reactivation rates are increased, particularly in older patients and those with advanced immunosuppression. These findings underscore the clinical relevance of routine CMV surveillance in the management of HIV infection.
Open AccessSeroepidemiology and Reactivation Rates of Cytomegalovirus in HIV-Positive Patients in Istanbul: A Retrospective Analysis
Cytomegalovirus (CMV) remains a major opportunistic pathogen in individuals with HIV. The aim of this study was to investigate the seroprevalence and reactivation rates of CMV among HIV-positive individuals. A total of 300 people with HIV presenting to the Istanbul Faculty of Medicine were enrolled. Serological assessments were performed using enzyme-linked immunosorbent assay (ELISA), while molecular analyses were conducted through PCR-based methods. Sociodemographic and clinical characteristics of the patients were also evaluated. Of the participants, 90% were male, with an age range of 18–76 years. Serological testing demonstrated CMV IgG positivity in 292 patients (97.3%) and CMV IgM positivity in 11 patients (4.07%). CMV DNA was detected in 91 patients (30.3%) by molecular assays, with viral loads ranging from p < 0.05) and was associated with lower CD4+ T lymphocyte counts. CMV disease was identified in 50 patients (16.7%), with organ involvement (64%) representing the most common clinical manifestation. CMV seropositivity is remarkably high in HIV-positive individuals, and reactivation rates are increased, particularly in older patients and those with advanced immunosuppression. These findings underscore the clinical relevance of routine CMV surveillance in the management of HIV infection.
- Open Access
- 10 March 2026
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 8 (2) , 305-310
The importance of prenatal diagnosis of congenital CMV infections and its relationship with prenatal clinical findings through molecular detection of CMV DNA in amniotic fluid samples
Aims: Congenital cytomegalovirus (cCMV) infection is a major cause of prenatal morbidity, frequently associated with central nervous system (CNS) involvement. This study aimed to determine the frequency of CMV DNA in amniotic fluid (AF) samples obtained from pregnancies with high-risk ultrasound findings suggestive of prenatal CMV infection during the second trimester and to evaluate the associated prenatal findings.Methods: This retrospective study included 238 pregnant women who underwent amniocentesis between January 2023 and November 2025 due to high-risk ultrasound findings identified by experienced perinatologists. CMV DNA in AF samples was detected using Real-Time PCR (RT-PCR). Maternal CMV IgG and IgM serological results were obtained from patient records. Prenatal ultrasound findings, serological data, and molecular test results were analyzed statistically. Results: CMV DNA was detected in 10 of 238 AF samples (4.20%; 95% confidence interval: 1.7-6.8%). In cases with CMV DNA positivity, prenatal ultrasound findings predominantly involved CNS anomalies (80%). CMV IgG positivity was observed in all CMV DNA-positive cases, while CMV IgM positivity was not detected in any patient. Conclusion: The strong association between CNS-predominant ultrasound anomalies and CMV DNA positivity underscores the diagnostic value of CMV DNA PCR testing in AF samples for prenatal CMV infection. These findings support the use of molecular diagnostic methods alongside ultrasonographic evaluation, as maternal serological screening alone may be insufficient for accurate prenatal CMV diagnosis.
- 10 March 2026
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 8 (2) , 305-310
Open AccessThe importance of prenatal diagnosis of congenital CMV infections and its relationship with prenatal clinical findings through molecular detection of CMV DNA in amniotic fluid samples
Aims: Congenital cytomegalovirus (cCMV) infection is a major cause of prenatal morbidity, frequently associated with central nervous system (CNS) involvement. This study aimed to determine the frequency of CMV DNA in amniotic fluid (AF) samples obtained from pregnancies with high-risk ultrasound findings suggestive of prenatal CMV infection during the second trimester and to evaluate the associated prenatal findings.Methods: This retrospective study included 238 pregnant women who underwent amniocentesis between January 2023 and November 2025 due to high-risk ultrasound findings identified by experienced perinatologists. CMV DNA in AF samples was detected using Real-Time PCR (RT-PCR). Maternal CMV IgG and IgM serological results were obtained from patient records. Prenatal ultrasound findings, serological data, and molecular test results were analyzed statistically. Results: CMV DNA was detected in 10 of 238 AF samples (4.20%; 95% confidence interval: 1.7-6.8%). In cases with CMV DNA positivity, prenatal ultrasound findings predominantly involved CNS anomalies (80%). CMV IgG positivity was observed in all CMV DNA-positive cases, while CMV IgM positivity was not detected in any patient. Conclusion: The strong association between CNS-predominant ultrasound anomalies and CMV DNA positivity underscores the diagnostic value of CMV DNA PCR testing in AF samples for prenatal CMV infection. These findings support the use of molecular diagnostic methods alongside ultrasonographic evaluation, as maternal serological screening alone may be insufficient for accurate prenatal CMV diagnosis.
- Open Access
- 26 October 2025
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 7 (6) , 738-742
Retrospective evaluation of serological and molecular test data related to CMV infections at İstanbul Faculty of Medicine Hospital
Aims: This study retrospectively evaluates the serological (CMV IgM and IgG) and molecular (CMV DNA PCR) test results of patients admitted to İstanbul Faculty of Medicine Hospital between 2021 and 2023 due to suspected cytomegalovirus (CMV) infection. The aim is to assess the diagnostic value of combining serological and molecular methods and to analyze CMV positivity across age and gender groups. Methods: This cross-sectional observational study included 1.649 patients who underwent CMV testing (CMV IgM, CMV IgG, and/or CMV DNA PCR) at the Medical Microbiology Laboratory of İstanbul Faculty of Medicine between January 1, 2021, and December 31, 2023. Serological tests were performed using ELISA (Vircell, Spain), and CMV DNA was quantified using real time PCR (QIAsymphony/Artus CMV QS-RGQ and cobas® 6800). Data were anonymized and analyzed statistically using SPSS v26.0. Mann-Whitney U, Chi-square, McNemar, and ROC tests were applied; p0.05), CMV DNA positivity varied significantly across age groups (p
- 26 October 2025
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 7 (6) , 738-742
Open AccessRetrospective evaluation of serological and molecular test data related to CMV infections at İstanbul Faculty of Medicine Hospital
Aims: This study retrospectively evaluates the serological (CMV IgM and IgG) and molecular (CMV DNA PCR) test results of patients admitted to İstanbul Faculty of Medicine Hospital between 2021 and 2023 due to suspected cytomegalovirus (CMV) infection. The aim is to assess the diagnostic value of combining serological and molecular methods and to analyze CMV positivity across age and gender groups. Methods: This cross-sectional observational study included 1.649 patients who underwent CMV testing (CMV IgM, CMV IgG, and/or CMV DNA PCR) at the Medical Microbiology Laboratory of İstanbul Faculty of Medicine between January 1, 2021, and December 31, 2023. Serological tests were performed using ELISA (Vircell, Spain), and CMV DNA was quantified using real time PCR (QIAsymphony/Artus CMV QS-RGQ and cobas® 6800). Data were anonymized and analyzed statistically using SPSS v26.0. Mann-Whitney U, Chi-square, McNemar, and ROC tests were applied; p0.05), CMV DNA positivity varied significantly across age groups (p